• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性硬皮病——环境触发因素与遗传触发因素的证据

Familial scleroderma--evidence for environmental versus genetic trigger.

作者信息

Stephens C O, Briggs D C, Whyte J, Artlett C M, Scherbakov A B, Olsen N, Gusseva N G, McHugh N J, Maddison P J, Welsh K I

机构信息

Royal Free Hospital, London.

出版信息

Br J Rheumatol. 1994 Dec;33(12):1131-5. doi: 10.1093/rheumatology/33.12.1131.

DOI:10.1093/rheumatology/33.12.1131
PMID:8000741
Abstract

Families with more than one case of scleroderma are unusual. Four families each with two members (in one case monozygotic twins) with scleroderma (systemic sclerosis, SSc) were identified. Clinical, immunogenetic and autoantibody studies were carried out. Multicase SSc families cited in the literature were reviewed. Each family pair shared cutaneous subset of disease severity, and SSc-associated autoantibody. HLA typing showed two pairs shared an HLA-DR allele associated with scleroderma (DR3 or DR5), while one also had alleles reported in association with their SSc-specific autoantibody. Review of dates and ages of onset suggested that the timing of onset of scleroderma is more likely to have an environmental trigger than to be encoded genetically.

摘要

有多例硬皮病的家庭并不常见。我们识别出了四个家庭,每个家庭中有两名成员患有硬皮病(系统性硬化症,SSc)(其中一个家庭是同卵双胞胎)。我们进行了临床、免疫遗传学和自身抗体研究。对文献中引用的多例SSc家庭进行了回顾。每对家庭成员都有相同的皮肤疾病严重程度亚组以及与SSc相关的自身抗体。HLA分型显示,有两对家庭成员共享与硬皮病相关的HLA - DR等位基因(DR3或DR5),而其中一对还拥有与他们的SSc特异性自身抗体相关报道的等位基因。对发病日期和年龄的回顾表明,硬皮病的发病时间更有可能由环境触发因素引起,而非由基因编码决定。

相似文献

1
Familial scleroderma--evidence for environmental versus genetic trigger.家族性硬皮病——环境触发因素与遗传触发因素的证据
Br J Rheumatol. 1994 Dec;33(12):1131-5. doi: 10.1093/rheumatology/33.12.1131.
2
Clinical, immunologic, and genetic features of familial systemic sclerosis.家族性系统性硬化症的临床、免疫学及遗传学特征
Arthritis Rheum. 2007 Jun;56(6):2031-7. doi: 10.1002/art.22647.
3
Connective tissue disease and autoantibodies in the kindreds of 63 patients with systemic sclerosis. The United Kingdom Systemic Sclerosis Study Group.63例系统性硬化症患者家族中的结缔组织病和自身抗体。英国系统性硬化症研究组。
Medicine (Baltimore). 1993 Mar;72(2):103-12. doi: 10.1097/00005792-199303000-00004.
4
An immunogenetic study of familial scleroderma.家族性硬皮病的免疫遗传学研究。
Ann Rheum Dis. 1994 Sep;53(9):614-7. doi: 10.1136/ard.53.9.614.
5
C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.C4A和C4B无效等位基因是日本患者不同类型系统性硬化症的遗传标记。
Clin Exp Rheumatol. 1998 Jan-Feb;16(1):55-60.
6
Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.30例系统性硬化症患者及其家族中的自身抗体与免疫遗传学
J Rheumatol. 1987 Aug;14(4):760-5.
7
Association of TAP1 and TAP2 with systemic sclerosis in Japanese.日本人群中TAP1和TAP2与系统性硬化症的关联
Clin Exp Rheumatol. 1996 Sep-Oct;14(5):513-21.
8
A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis.
Arthritis Rheum. 1986 Oct;29(10):1274-7. doi: 10.1002/art.1780291014.
9
Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.针对核仁抗原PM-Scl的血清自身抗体。临床及免疫遗传学关联。
Arthritis Rheum. 1992 Oct;35(10):1211-7. doi: 10.1002/art.1780351014.
10
Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.系统性硬化症中补体第二和第四成分及其基因的分子异质性,以及HLA等位基因A1、B8与局限性系统性硬化症的关联,HLA等位基因DR5与弥漫性系统性硬化症的关联。
Exp Clin Immunogenet. 1998;15(2):90-9. doi: 10.1159/000019059.

引用本文的文献

1
Immunopathogenesis of Juvenile Systemic Sclerosis.青少年系统性硬皮病的免疫发病机制。
Front Immunol. 2019 Jun 25;10:1352. doi: 10.3389/fimmu.2019.01352. eCollection 2019.
2
Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.系统性硬化症患者中CYP2D6氧化的基因多态性
Eur J Clin Pharmacol. 2009 Oct;65(10):971-6. doi: 10.1007/s00228-009-0662-3. Epub 2009 May 15.
3
Genetics and proteomics in scleroderma.硬皮病中的遗传学与蛋白质组学
Curr Rheumatol Rep. 2005 Apr;7(2):129-34. doi: 10.1007/s11926-005-0065-0.